RIG
46
-8
V
70
2
HPE
68
-4
M
31
-2
YUM
48
-2
ADSK
72
-3
RL
76
-3
AAP
39
-3
ADBE
55
6
FSLR
40
-3
WDC
41
-6
OI
45
-5
EXC
41
-2
EQIX
60
-3
MRK
23
-5
XOM
48
-2
DG
10
-2
DVN
25
-3
TGT
52
2
SYK
73
5
RIG
46
-8
V
70
2
HPE
68
-4
M
31
-2
YUM
48
-2
ADSK
72
-3
RL
76
-3
AAP
39
-3
ADBE
55
6
FSLR
40
-3
WDC
41
-6
OI
45
-5
EXC
41
-2
EQIX
60
-3
MRK
23
-5
XOM
48
-2
DG
10
-2
DVN
25
-3
TGT
52
2
SYK
73
5
Financhill
Back

Cellectar Biosciences Vs. Perspective Therapeutics Industry Stock Comparison

Sell
47

CLRB
Cellectar Biosciences

Last Price:
2.08
Seasonality Move:
-2.36%
Sell
30

CATX
Perspective Therapeutics

Last Price:
9.93
Seasonality Move:
28.97%
Sell
47
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $2.14. The Score for CLRB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $10.67. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $2.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $10.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 58.34 Buy
Chaikin Money Flow: 136682 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.04 - 2.12) Buy
Bollinger Bands (100): (1.95 - 2.43) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 32.97 Sell
Chaikin Money Flow: -548254 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.5 - 12.8) Sell
Bollinger Bands (100): (11.26 - 14.34) Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.08 Buy
20-day SMA: 2.07 Buy
50-day SMA: 2.08 Buy
200-day SMA: 2.82 Sell
8-day EMA: 2.1 Buy
20-day EMA: 2.08 Buy
50-day EMA: 2.12 Buy
200-day EMA: 2.48 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.72 Sell
20-day SMA: 11.96 Sell
50-day SMA: 12.97 Sell
200-day SMA: 12.78 Sell
8-day EMA: 11.47 Sell
20-day EMA: 11.93 Sell
50-day EMA: 12.56 Sell
200-day EMA: 11.75 Sell

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):